Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
It was developed by Astellas Pharma and was approved in the United States in July 2012
even at the dose at which Staurosporine itself induced tumors
is an orally bioavailable small-molecule androgen receptor modulator and CYP17 lyase inhibitor with potential antiandrogen activity
is a potent and selective Aldehyde Dehydrogenase-2 Agonist
Chemical Name: 7-hydroxy-8-methyl-15-oxo-5
5'-O-DMT-3'-O-TBDMS-Ac-rC - CAS# 123956-65-0 Size:Contact [email protected] for quotation It was developed by Astellas5' O DMT 3' O TBDMS Ac rC is a modified nucleoside and can be used to synthesize DNA or RNA. Product information CAS Number: 123956 65 0 Molecular Weight: 701. 88 Formula: C38H47N3O8Si Chemical Name: N {1 [(2R,3R,4S,5R) 5 {[bis(4 methoxyphenyl)(phenyl)methoxy]methyl} 4 [(tert butyldimethylsilyl)oxy] 3 hydroxyoxolan 2 yl] 2 oxo 1,2 dihydropyrimidin 4 yl}acetamide Smiles:
US$ 29.95
US$ 29.95
US$ 29.95
US$ 29.95
US$ 29.95